NASDAQ:ZCMD 延时15分钟

成交量

Wei Guang Yang: Wei Guang Yang is the founder of Zhongchao, Inc. and Zhongchao Medical Technology (Shanghai) Corp., both founded in 2012. He held the titles of Chairman, President & Chief Executive Officer and General Manager respectively. Mr. Yang's former jobs include Co-Chief Executive Officer & Director at TradeUP Acquisition Corp., Director at Global Alliance For Medical Education from 2013 to 2016, and General Manager at MedWorks Corp. from 2005 to 2012. Mr. Yang received his undergraduate degree from Gannan Medical University in 2005 and his graduate degree from Capital Medical University in 2008.

Pei Xu: Ms. Pei Xu is a Chief Financial Officer, Secretary & Director at Zhongchao, Inc., a Chief Financial Officer at Zhongchao Medical Technology (Shanghai) Corp. and an Independent Director at Estrella Immunopharma, Inc. She is on the Board of Directors at Zhongchao, Inc. and Estrella Immunopharma, Inc. Ms. Xu was previously employed as a Financial Director by Otsuka (China) Investment Co., Ltd. She received her undergraduate degree from Jiangxi University of Finance & Economics.

John Conrad General: John Conrad General currently works at Zhongchao, Inc., as Independent Director from 2019. Mr. General also formerly worked at AT&T Corp., as Financial Director from 1986 to 2003, 20230930-DK-Butterfly-1, Inc., as Manager-Financial Operations from 2010 to 2013, and Value Services, Inc., as Manager-Financial Operations from 2010 to 2013. Mr. General received his Masters Business Admin degree from Rutgers State University of New Jersey and undergraduate degree from Fairleigh Dickinson University.

Kevin Dean Vassily: Kevin Dean Vassily is currently Director at Autozi Lianhe E-Commerce (Beijing) Co., Ltd. Current roles also include Independent Director at Thunder Power Holdings, Inc. (since 2024), Aimfinity Investment Corp. I (since 2023), Inkstone Feibo Acquisition Corp., Zhongchao, Inc. (since 2020), Tungray Technologies, Inc. (since 2024), Autozi Internet Technology (Global) Ltd. (since 2024), CTW Cayman (since 2025), and Fortune Joy International Acquisition Corp. (since 2021). Former positions include Associate Director-Research at KeyBanc Capital Markets, Inc. (2015 2018), Associate Director of Research at Pacific Crest Securities LLC, Research Director at Pacific Epoch (2010 2014), Independent Director at Denali Capital Acquisition Corp. and Feutune Light Acquisition Corp., Financial Analyst at Applied Materials, Inc., Senior Research Analyst at Susquehanna Financial Group LLLP (2003 2006), Vice President-Market Development at Facteus, Inc. (2019 2021), Chief Financial Officer at iPower, Inc. (2021 2025), Senior Research Analyst at Susquehanna International Group LLP (2001 2003), Vice President at Thomas Weisel Partners LLC (2001 2003), Research Associate at Lehman Brothers Real Estate Group, and Vice President & Senior Research Analyst at Thomas Weisel Partners (2001 2003). Education includes undergraduate degree from Denison University and MBA from Tuck School of Business at Dartmouth.

Dan Li: Dan Li currently works at Zhongchao, Inc., as Independent Director from 2019. Dr. Li also formerly worked at EPS Holdings, Inc., as Manager-Medicine Management Department from 2009 to 2011. Dr. Li received her doctorate degree from Keio University, graduate degree from Peking University, and undergraduate degree from North China University of Science & Technology.

众巢医学